Cargando…
Neoadjuvant therapy for pancreatic cancer
Multimodal treatment including surgery and chemotherapy is considered the gold standard treatment of pancreatic cancer by most guidelines. Neoadjuvant therapy (NAT) has been seen as a possible treatment option for resectable, borderline resectable and locally advanced PaC. The aim of this paper is t...
Autores principales: | Gugenheim, Jean, Crovetto, Anna, Petrucciani, Niccolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502083/ https://www.ncbi.nlm.nih.gov/pubmed/34628591 http://dx.doi.org/10.1007/s13304-021-01186-1 |
Ejemplares similares
-
Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits
por: Heinrich, Stefan, et al.
Publicado: (2017) -
Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy
por: Bittoni, Alessandro, et al.
Publicado: (2014) -
Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer
por: Smaglo, Brandon G.
Publicado: (2023) -
Developments and challenges in neoadjuvant therapy for locally advanced pancreatic cancer
por: Zhou, Bo, et al.
Publicado: (2023) -
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
por: Ren, Lei, et al.
Publicado: (2020)